TGF Beta-Induced Apoptosis in B-Lymphocytes
TGF Beta-Induced Apoptosis in B-Lymphocytes
批准号:
7743033
负责人:
Philip H Howe
金额:
$29.64万
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-12-10 至 2013-11-30
关键词:
AnimalsApoptosisApoptosis RegulatorApoptoticB-LymphocytesBIM Bcl-2-binding proteinBiological AssayCell DeathCell LineCellsClonal DeletionDataDevelopmentFamily memberFundingGenesGenetic TranscriptionHematologic NeoplasmsHomeostasisImmediate-Early GenesImmune systemIn VitroInduction of ApoptosisInterleukin-3Interleukin-7LeadLeukemic CellLymphocyteLymphoidMAPK phosphataseMaintenanceMediatingMessenger RNAMitochondriaMitogen-Activated Protein KinasesMolecularMusMyeloid CellsPathway interactionsPhenotypePhosphoric Monoester HydrolasesPhosphorylationPlayPolyubiquitinationProtein DephosphorylationProtein phosphataseProteinsRegulationRegulatory PathwayResearchRibosomesRoleSelf ToleranceStressT-Cell DevelopmentTestingTranscriptional RegulationTransforming Growth FactorsTranslational RegulationUbiquitinUbiquitinationWithdrawalautoreactive B cellbasecytokinein vivoleukemia/lymphomamRNA Expressionpro-apoptotic proteinpublic health relevanceresponsesystemic autoimmune diseasetumorigenesisubiquitin-protein ligase
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Transforming growth factor ? (TGF?) and the pro-apoptotic Bcl-2 family member Bim, Bcl-2 interacting mediator of cell death, play critical roles in the development and homeostasis of the immune system. Targeted disruption, in mice, of either the TGF? or Bim gene results in an accumulation of lymphoid and myeloid cells, a perturbation of T cell development, and ultimately, the animals succumb to systemic autoimmune diseases. These phenotypes underscore the essential roles of TGF? and Bim in T cell development and in the negative selection or clonal deletion of autoreactive B cells that is critical for normal B lymphocyte development and the maintenance of self tolerance. We have investigated the molecular mechanisms by which TGF? aids in maintenance of self tolerance through its induction of apoptosis in B lymphocytes. We have demonstrated that TGF?-induced cell death is mediated through its induction of Bim, providing the first evidence that Bim expression levels are directly influenced by a pro-apoptotic cytokine rather than being upregulated in response to pro-survival factor (i.e. IL-3, IL-7) withdrawal or stress induction. TGF? induction of Bim was shown to be Smad3-dependent and abrogated by activation of survival pathways. Our preliminary data has identified two potential modulators of TGF?-mediated Bim induction, the immediate early gene MAPK phosphatase 2 (MKP2) and the transcriptional co-regulator Runx1/AML1. Herein, we wish to test the hypotheses that TGF? induces MKP2 to rapidly target existing Bim levels by inactivation of the MAP kinase Erk, resulting in dephosphorylation and escape of Bim from ubiquitin-mediated proteasomal decay. Additionally, and for sustained modulation of Bim, we postulate that TGF? induces the transcriptional co-regulator Runx1/AML1, which interacts with Fox03 to transactivate Bim mRNA expression. Interestingly, Runx1 induction by TGF? is mediated through a non-transcriptional mechanism involving translational regulation through an internal ribosome entry (IRES) mechanism. Thus, TGF? not only induces de novo Bim mRNA transcription but also assures that the pathway that results in degradation of its product is inhibited, resulting in Bim protein accumulation and ultimately mitochondrial-mediated cell death.
PUBLIC HEALTH RELEVANCE: The pro-apoptotic protein Bim is a key regulator of cell death in B lymphocytes and its deregulated expression underlies many hematological malignancies. The successful pursuit of these aims will lead to a better understanding of the regulation of Bim at both the transcriptional and post-translational mechanisms. Our research may identify factors and important regulatory pathways that could be used therapeutically to modulate Bim expression in vivo.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Integrative Training in Oncogenic Signaling
-
批准号:10650782
-
项目类别:
-
资助金额:$32.7万
-
财政年份:2016
-
负责人:Philip H Howe
-
依托单位:
Integrative Training in Oncogenic Signaling
-
批准号:10267821
-
项目类别:
-
资助金额:$42.06万
-
财政年份:2016
-
负责人:Philip H Howe
-
依托单位:
Integrative Training in Oncogenic Signaling
-
批准号:9312769
-
项目类别:
-
资助金额:$31.8万
-
财政年份:2016
-
负责人:Philip H Howe
-
依托单位:
Integrative Training in Oncogenic Signaling
-
批准号:10454409
-
项目类别:
-
资助金额:$36.07万
-
财政年份:2016
-
负责人:Philip H Howe
-
依托单位:
TGFbeta-regulated epithelial-mesenchymal transition (EMT)
-
批准号:10548115
-
项目类别:
-
资助金额:$37.37万
-
财政年份:2011
-
负责人:Philip H Howe
-
依托单位:
TGF-regulated EMT
-
批准号:8327940
-
项目类别:
-
资助金额:$19.58万
-
财政年份:2011
-
负责人:Philip H Howe
-
依托单位:
TGF-regulated EMT
-
批准号:8022057
-
项目类别:
-
资助金额:$12.07万
-
财政年份:2011
-
负责人:Philip H Howe
-
依托单位:
TGF-regulated EMT
-
批准号:8403717
-
项目类别:
-
资助金额:$28.77万
-
财政年份:2011
-
负责人:Philip H Howe
-
依托单位:
TGF-regulated EMT
-
批准号:8593288
-
项目类别:
-
资助金额:$29.69万
-
财政年份:2011
-
负责人:Philip H Howe
-
依托单位:
TGFbeta-regulated epithelial-mesenchymal transition (EMT)
-
批准号:10292840
-
项目类别:
-
资助金额:$37.31万
-
财政年份:2011
-
负责人:Philip H Howe
-
依托单位:
TGF-regulated EMT
-
批准号:8784197
-
项目类别:
-
资助金额:$30.61万
-
财政年份:2011
-
负责人:Philip H Howe
-
依托单位:
TGF-regulated EMT
-
批准号:8206542
-
项目类别:
-
资助金额:$30.61万
-
财政年份:2011
-
负责人:Philip H Howe
-
依托单位:
Cancer Biology
-
批准号:10377472
-
项目类别:
-
资助金额:$2.53万
-
财政年份:2009
-
负责人:Philip H Howe
-
依托单位:
Cancer Biology
-
批准号:10589906
-
项目类别:
-
资助金额:$2.53万
-
财政年份:2009
-
负责人:Philip H Howe
-
依托单位:
TGF BETA--INDUCED APOPTOSIS IN B LYMPHOCYTES
-
批准号:6124670
-
项目类别:
-
资助金额:$20.84万
-
财政年份:1998
-
负责人:Philip H Howe
-
依托单位:
TGF beta-induced apoptosis in B-lymphocytes
-
批准号:6730234
-
项目类别:
-
资助金额:$27.54万
-
财政年份:1998
-
负责人:Philip H Howe
-
依托单位:
TGF Beta-Induced Apoptosis in B-Lymphocytes
-
批准号:8326810
-
项目类别:
-
资助金额:$9.75万
-
财政年份:1998
-
负责人:Philip H Howe
-
依托单位:
TGF Beta-Induced Apoptosis in B-Lymphocytes
-
批准号:8196922
-
项目类别:
-
资助金额:$27.01万
-
财政年份:1998
-
负责人:Philip H Howe
-
依托单位:
TGF Beta-Induced Apoptosis in B-Lymphocytes
-
批准号:7989389
-
项目类别:
-
资助金额:$19.01万
-
财政年份:1998
-
负责人:Philip H Howe
-
依托单位:
TGF BETA--INDUCED APOPTOSIS IN B LYMPHOCYTES
-
批准号:2743621
-
项目类别:
-
资助金额:$20.65万
-
财政年份:1998
-
负责人:Philip H Howe
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: